One extra chromosome is present in persons diagnosed with Down syndrome. The medical term that is used to indicate this medical condition is called “Trisomy”. It’s also popular by the name Trisomy 21. This additional copy alters the physical and mental development of the baby, posing mental and physical difficulties for the child and, as a result, leading to developmental disabilities.
Although an extra chromosome is well known as the causative agent of Down Syndrome, there is no definitive explanation for why it arises or what factors are involved. The mother’s age influences the likelihood of having a baby with Down syndrome. When a woman is younger when she becomes pregnant, her chances of having a baby with down syndrome are lower than when she is 35 or older and has a higher chance of having a pregnancy directly impacted by down syndrome.
Managing The Symptoms Of Down Syndrome
Although there is no curative therapy for Down syndrome, there are many support and educational programs available to individuals with the condition as well as their families. Children diagnosed with this condition frequently achieve developmental milestones. Irrespective of intellectual ability, school is an essential part of a child’s life with Down syndrome.
CBD For Down Syndrome Symptoms
According to some recent studies, cannabis may be able to alleviate Down Syndrome symptoms. Results of these studies suggest that the endocannabinoid system in your body is involved in down syndrome and that cannabinoids may help in alleviating the symptoms of this condition. Cannabinoid-based treatments that target the system, according to the studies, may help with symptoms.
For instance, take a look at a review from 2018. The cannabinoids CBD and THC were discovered to minimize the occurrence of amyloid plaques and damaged neurons in animals and humans suffering from a variety of diseases. Cannabinoids are reported to protect against a variety of other symptoms of Down syndrome, including impulsive behavior and difficulty maintaining attention, as well as gastrointestinal problems, sleeping problems, and seizures. Parents of children suffering from Down syndrome also confirm this.
In a 2008 study, researchers discovered that people with down syndrome have higher levels of activity in their CB2 cannabinoid receptors and the enzyme DAAH, which helps in the breakdown of anandamide in their beta-amyloid plaques. The results of the study do not support the hypothesis that the endocannabinoid system is dysfunctional in adults with Down syndrome. It implies that cannabinoid-based treatments aimed at the system could help alleviate symptoms.